Source: Acta neuropathologica communications. Unidade: FM
Subjects: DOENÇAS NEURODEGENERATIVAS, DOENÇA DE ALZHEIMER, BIOMARCADORES
ABNT
RIZZI, Liara e GRINBERG, Lea Tenenholz. Exploring the significance of caspase-cleaved tau in tauopathies and as a complementary pathology to phospho-tau in Alzheimer's disease: implications for biomarker development and therapeutic targeting. Acta neuropathologica communications, v. 12, n. 1, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/59005. Acesso em: 18 nov. 2024.APA
Rizzi, L., & Grinberg, L. T. (2024). Exploring the significance of caspase-cleaved tau in tauopathies and as a complementary pathology to phospho-tau in Alzheimer's disease: implications for biomarker development and therapeutic targeting. Acta neuropathologica communications, 12( 1). doi:10.1186/s40478-024-01744-9NLM
Rizzi L, Grinberg LT. Exploring the significance of caspase-cleaved tau in tauopathies and as a complementary pathology to phospho-tau in Alzheimer's disease: implications for biomarker development and therapeutic targeting [Internet]. Acta neuropathologica communications. 2024 ; 12( 1):[citado 2024 nov. 18 ] Available from: https://observatorio.fm.usp.br/handle/OPI/59005Vancouver
Rizzi L, Grinberg LT. Exploring the significance of caspase-cleaved tau in tauopathies and as a complementary pathology to phospho-tau in Alzheimer's disease: implications for biomarker development and therapeutic targeting [Internet]. Acta neuropathologica communications. 2024 ; 12( 1):[citado 2024 nov. 18 ] Available from: https://observatorio.fm.usp.br/handle/OPI/59005